Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

• Asıl Yazarlar: Cristóbal Morales (Yazar), Juan Francisco Merino-Torres (Yazar), Paloma Moreno-Moreno (Yazar), María Lainez (Yazar), Iñigo Tejado (Yazar), Alfredo Yoldi (Yazar), Sonsoles Gutiérrez Medina (Yazar), Alfonso Soto (Yazar), Manuel A Botana (Yazar), Virginia Bellido (Yazar), Irene Caballero (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BioExcel Publishing Ltd, 2022-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: This study aims to evaluate dapagliflozin in patients with type 2 diabetes (T2D) in clinical practice in Spain. Methods: This is a retrospective study including adults with T2D under stable antidiabetic therapy, with either dapagliflozin or sitagliptin ≥6 months, before inclusion. Data a...